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ABSTRACT: The sulfoxide synthase EgtB represents a unique family of nonheme iron enzymes that catalyze the for-
mation of a C–S bond between N--trimethyl histidine and -glutamyl cysteine, which is the key step in the biosynthesis 
of ergothioneine an important amino acid related to aging. A controversy has arisen regarding its catalytic mechanism 
related to the function of the active site Tyr377 residue. The biosynthesis of ergothioneine in EgtB shows structural similar-
ities to cysteine dioxygenase that transfers two oxygen atoms to the thiolate group of cysteine. The question; therefore, is 
how EgtB enzymes catalyze the C‒S bond formation reaction, while preventing a dioxygenation of its cysteinate substrate. 
In this work we present a quantum mechanics/molecular mechanics study into the mechanism of sulfoxide synthase en-
zymes as compared to cysteine dioxygenase and present pathways for both reaction channels in EgtB. We show that EgtB 
contains a conserved tyrosine residue that reacts via proton-coupled-electron-transfer with the iron(III)-superoxo species 
and creates an iron(III)-hydroperoxo intermediate and thereby prevents the possible thiolate dioxygenation side-reaction. 
The nucleophilic C‒S bond formation step happens subsequently concomitant to relay of the proton of the iron(II)-
hydroperoxo back to Tyr377. This is the rate determining step in the reaction cycle and is followed by hydrogen atom 
transfer from the CE1‒H group of trimethyl histidine substrate to iron(II)-superoxo. In the final step a quick and almost 
barrierless sulfoxidation leads to the sulfoxide product complexes. The work highlights a unique machinery and active 
site set-up that leads to the formation of a sulfoxide synthase reaction.  
Introduction. 
Nonheme iron dioxygenases are common and highly 
versatile enzymes in biology that participate in a range of 
vital functions for human health including DNA and RNA 
repair mechanisms,1 the biosynthesis of R-4-
hydroxyproline,2 and the metabolism of toxic cysteine in 
the body.3 As such, their function is critical for the biosys-
tem and understanding the mechanism of action of these 
dioxygenases is important in the field of drug develop-
ment therapies against a number of diseases. In particu-
lar, elevated levels of cysteine in the body have been cor-
related with a range of neurological diseases, including 
Alzheimer’s and Parkinson’s.4  
In general, nonheme iron dioxygenases have a con-
served structure with a central iron atom that is linked to 
the protein through nonheme interactions with either 
carboxylate (Asp/Glu) and/or histidine amino acid side 
chains.5 A common motif found in these dioxygenases is 
the facial orientation of the metal with two histidine and 
one carboxylate ligand, i.e. a 2-His/1-Asp(or 1-Glu) ligand 
environment. In octahedral symmetry, therefore, three 
ligand sites are occupied by the 2-His/1-Asp protein envi-
ronment and the other three sites are available for bind-
ing of molecular oxygen and (co)-substrates.6 For in-
stance, the -ketoglutarate dependent dioxygenases uti-
lize -ketoglutarate (KG) as a co-substrate on a non-
heme iron center, which in a reaction with an iron(III)-
superoxo species is converted into succinate and CO2 and 
leaves a high-valent iron(IV)-oxo intermediate. The latter 
has been designated as the active oxidant in many non-
heme iron dioxygenases and reacts with substrates effi-
ciently through aliphatic hydrogen atom abstraction reac-
tions or oxygen atom transfer.5,7 By contrast, several other 
nonheme iron dioxygenases do not use an extra co-
substrate. An example of this is (S)-p-hydroxymandelate 
synthase that utilizes p-hydroxyphenyl pyruvate as a sub-
strate, which in a reaction with an iron(III)-superoxo 
leads to its decarboxylation and subsequent stereo- and 
regiospecific hydroxylation.8 
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Figure 1. Active site structures of EgtB (left) and CDO (right) enzymes as taken from the 4X8D and 4IEV pdb files. The facial 3-
His ligand system is highlighted in wine-red and EgtB substrates (TMH and GC) are shown in blue and purple. 
Despite the fact that most nonheme iron dioxygenases 
contain a typical 2-His/1-Asp facial triad, actually a num-
ber of sulfur-activating nonheme iron dioxygenases utilize 
a 3-His ligand coordination environment instead. One of 
those is cysteine dioxygenase (CDO) that converts a cys-
teine amino acid into cysteine sulfinic acid as an initial 
step in the cysteine catabolism in the body.3,9 Another 
sulfur-activating nonheme iron enzyme is the ergothi-
oneine biosynthesis protein EgtB, which catalyzes the C–S 
bond formation step between -glutamyl cysteine (GC) 
and N--trimethyl histidine (TMH) and the subsequent 
sulfoxidation of its product.10 Thus, enzymes that replace 
C–H bonds with C–S bonds are rare, and only few have 
been reported over the years.11 EgtB, to be specific, shows 
structural similarity to CDO with a central iron atom 
bound to the protein via a 3-His ligand orientation, alt-
hough the enzymes are unrelated and also fold different-
ly. In bacteria ergothioneine is generated to protect 
against oxidative stress,12 whereas in humans it may act as 
a reactive oxidative species.13 Understanding the mecha-
nism for the biosynthesis of natural compounds relevant 
to aging processes in the body are important for pharma-
ceutical and medical development. 
The active site structures of EgtB and CDO enzymes are 
shown in Figure 1, as taken from the 4X8D and 4IEV pro-
tein databank (pdb) files.14,15 Both of these are from sub-
strate-bound crystal structure coordinates and show the 
iron bound in a facial 3-His coordination environment. 
Substrate cysteinate in CDO binds as a bidentate ligand 
through the amine and thiolate groups, while its carbox-
ylate is involved in a salt bridge with an arginine residue 
(Arg60) and is locked in hydrogen bonding interactions 
with a tyrosinate (Tyr58 and Tyr157) and histidine (His155) 
side chain. Note that the active site contains the unusual 
Tyr157-Cys93 crosslink with a covalent bond between the 
two amino acid residues. It is believed this crosslink has a 
steric effect on the overall reaction mechanism.16 The final 
ligand position of the metal is reserved for molecular oxy-
gen. Density functional theory (DFT) modelling and 
quantum mechanics/molecular mechanics (QM/MM) 
studies showed the catalytic cycle to proceed with dioxy-
gen binding to form an iron(III)-superoxo intermediate.17 
The latter reacts with the thiolate group via oxygen atom 
transfer (OAT) to form a sulfoxide and an iron(IV)-oxo 
species. A final step relays the oxo to the sulfur atom of 
cysteine sulfoxide to form cysteine sulfinic acid products.   
EgtB, by contrast to CDO, binds two individual sub-
strates, namely GC and TMH through their thiolate and 
imidazole substituents, respectively. These structures are 
held in position through hydrogen bonding interactions 
between each other as well as with amino acid side chains 
from, e.g. Arg87 and Arg90 (Figure 1). The final ligand site 
of the metal remains open for molecular oxygen to bind. 
Consequently, both CDO and EgtB form an initial 
iron(III)-superoxo intermediate in their catalytic cycles 
and both have a sulfide substrate ligand. Technically, 
therefore, a CDO-type mechanism could apply to EgtB 
leading to the dioxygenation of GC substrate. However, 
the latter is not known to form but instead the enzyme 
reacts as a sulfoxide synthase.     
CDOEgtB
GC
Tyr377
TMH
His134 His51
His138
Arg87
Arg90
His88
His86 His140
Arg60 Tyr58
Tyr157
Cys93
Cys
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Scheme 1. Proposed reaction mechanisms of substrate(s) activation by EgtB via consecutive oxygen atom trans-
fer (OAT) or proton transfer (PT) leading to dioxygenation or sulfoxide synthase activity.  
Density functional theory modelling of active site mod-
els of EgtB in a polarized continuum model proposed a 
reaction mechanism starting with sulfoxidation (oxygen 
atom transfer, OAT) of GC followed by C–S bond for-
mation and deprotonation (PT) to form products: Path-
way I in Scheme 1.18 However, this mechanism is in con-
tradiction to recent kinetics and mutation studies that 
implicated an important function of the Tyr377 residue.
14,19 
Moreover, an initial sulfoxidation step could subsequently 
lead to a dioxygenation of the sulfur-containing substrate 
in analogy to CDO enzymes (CDO Pathway in Scheme 1 
leading to product C), which is not known to occur in 
Nature. The question, therefore, is why EgtB does not 
react through a dioxygenation of the thiolate group of the 
substrate and/or how it prevents this thiolate dioxygena-
tion side-reaction. As the co-factor environment appears 
to play an important role in the reaction mechanism, we 
decided to gain an answer to this question by studying 
the reaction mechanism using the QM/MM methodology 
and by studying various alternative mechanisms.  
The second pathway displayed in Scheme 1 highlights 
an alternative mechanism investigated here with a critical 
role for Tyr377. Again the EgtB catalytic cycle starts with 
binding of both substrates (GC and N--trimethyl histi-
dine, TMH) on the iron center followed by molecular ox-
ygen to create an iron(III)-superoxo structure (A in 
Scheme 1). We then considered various protonation states 
of the conserved tyrosine residue (Tyr377) in the active site 
that could lead to protonation and/or hydrogen atom 
transfer to the superoxo group to form an iron(III/II)-
hydroperoxo species either in conjunction with or fol-
lowed by a C‒S bond formation step between the two 
substrates (structure E). Thereafter a proton transfer (PT) 
from the TMH imidazole group to either iron(III)-
superoxo or to Tyr377 gives structure F. Finally, an oxygen 
atom transfer from the metal to the linked substrates 
leads to the sulfoxide synthase products (G). Site directed 
mutations that replaced Tyr377 by phenylalanine gave evi-
dence of key functional components in the reaction 
mechanism as the C–S bond between the substrates was 
not formed in the mutants, but instead a dioxygenation of 
the thiolate group of GC took place in a CDO-like mech-
anism.19  
In this work a novel catalytic reaction cycle for EgtB is 
presented as based on detailed QM/MM studies that take 
the full protein into consideration. Furthermore, many 
alternative side-reactions, including the one leading to 
dioxygenation of GC have been studied. The work gives 
explanations as to how the dioxygenation side reaction is 
prevented and highlights the functions of several active 
site residues. In particular, the work shows that the fast 
CDO-type side reaction is prevented through a proton 
coupled electron transfer from Tyr377 to iron(III)-superoxo 
group, which enables the slower C–S bond formation to 
take place and blocks the sulfur dioxygenation side-
reaction. 
 
Methods. 
We investigated the catalytic mechanism for sulfoxide 
synthase between TMH and GC followed by oxygen atom 
transfer to obtain the ergothioneine product. We use a 
mixture of density functional theory (DFT) calculations 
on model complexes and full quantum mechan-
ics/molecular mechanics (QM/MM) studies on the full 
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protein. We will focus in the main text on the QM/MM 
results only; however, all details of the complete set of 
results are given in the Supporting Information.  
 
Set-up of the system. Our studies started from the 
crystal structure coordinates of the substrate bound 
iron(II) resting state complex.14 The methods and proce-
dures follow previously tested and benchmarked proto-
cols that have been published in detail elsewhere,20,21 but 
will be briefly summarized here. Initially, the substrates-
bound resting state was converted into an iron(III)-
superoxo structure by manually adding a superoxo group. 
Subsequently, protons were added to the structure using 
the typical amino acid features at pH 7 with the pdbtopqr 
software package.22 In this case, all Glu and Asp residues 
and the side-chain carboxylate group of the substrate 
were taken in the deprotonated form, whereas all Lys and 
Arg residues were protonated. Histidine residues (His8, 
His51, His85, His92, His134, His136, His138, His200, His264, His276 
and His417) and the substrate imidazole moieties were 
taken in their singly protonated form. An iterative solva-
tion procedure was applied to the constraint protein 
structure in a sphere with radius of 40Å (Figure S1, Sup-
porting Information), which resulted in a final structure 
of 32,992 atoms including 8,739 TIP3P water molecules. 
In the next stage of the model set up, the chemical sys-
tem was heated and equilibrated to room temperature 
with the backbone atoms fixed using the Charmm 
forcefield.23 This was followed by a full molecular dynam-
ics simulation for 1000 ps without geometric constraints 
in Charmm (see Figure S2 in the Supporting Information). 
Several snapshots from the MD simulation were selected 
as starting points for the QM/MM calculations, namely 
after 945, 950 and 955 ps; designated snapshots Sn945, 
Sn950 and Sn955. Key structures were optimized in all snap-
shots, while the full reaction mechanism was investigated 
for Sn950 only.  
 
QM/MM calculations. The chemical system was sepa-
rated into QM and MM regions, whereby the border re-
gion was described through hydrogen atom link-atoms 
and the interactions between the quantum mechanics 
and molecular mechanics were described by electrostatic 
embedding.24 The QM region contained the atoms high-
lighted in Scheme 2. Thus, the histidine ligands were ab-
breviated to methylimidazole, while the TMH substrate 
also included the carboxylate group. The GC substrate 
comprised the full cysteinate residue and was cut after the 
peptide bond. In addition to the direct ligands of the iron 
we included two crystal water molecules and the Tyr377 
and Arg90 side chains. 
The QM region was calculated with Turbomole25 at the 
DFT level of theory, whereas the Charmm forcefield23 was 
run through DL-POLY26,27 and the two software packages 
interfaced through ChemShell.28 All initial geometry op-
timizations and reaction scans utilized the unrestricted 
B3LYP hybrid density functional method,29 in combina-
tion with an SV(P) basis set on all atoms: basis set BS1.30 
Single point calculations were performed on the opti-
mized geometries with an all-electron Wachters-type ba-
sis set on iron and 6-311+G* on the rest of the atoms: basis 
set BS2.31 
Scheme 2. Atoms included in the QM region. Wiggly 
lines identify bonds on the border of the QM and 
MM regions.  
To test the effect of the density functional method on 
the spin-state energies, we did single point calculations at 
the QM/MM level of theory on several structures using 
the BP8632 and PBE033 protocols. However, no dramatic 
changes in spin state ordering and relative energies were 
obtained, so that we will focus on the B3LYP results only. 
A recent computational study on substrate sulfoxidation 
by nonheme iron(IV)-oxo complexes using more than 40 
different computational methods and procedures showed 
that B3LYP reproduces experimental enthalpies of activa-
tion within 4 kcal mol–1 and perfectly predicts regioselec-
tivities and Hammett trends.34 
 
Results and Discussion. 
Before we discuss the reaction mechanisms of EgtB and 
how it compares to CDO, we did an extensive set of calcu-
lations to validate the model, density functional method 
and basis sets. In particular, we compared the structure 
and spin-state ordering of key intermediates as compared 
to CDO enzymes and model structures.17,35 
 
Model testing. Figure 2 displays QM/MM optimized 
geometries in the lowest lying singlet, triplet and quintet 
spin states of the iron(III)-superoxo structures (Re) for 
EgtB and CDO enzymes, whereby the data of the latter 
was taken from Ref 17b. Structurally, there are some key 
differences between the two systems that may affect their 
reactivities. In CDO, the superoxo moiety is located in a 
very small binding pocket surrounded by mostly apolar 
residues including Leu95 and Ile133 (not shown in Figure 2) 
and the cross-linked pair Tyr157-Cys93. By contrast, the 
superoxo group in EgtB is found in a polar environment 
with a chain of water molecules connecting it to a tyro-
sine residue (Tyr377), but also a Trp59 and Gln55 (Support-
ing Information, Figure S4).   
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Figure 2. Optimized geometries of low-lying spin states of the iron(III)-superoxo reactant of EgtB (left) and CDO (right) as ob-
tained with QM/MM. Data for CDO for snapshot Sn250 from Ref 17b. Bond lengths are in angstroms for snapshots Sn950, Sn945 
and Sn955.  
Two of these water molecules and the Tyr377 side chain 
were included in the QM region of the calculations. An-
other minor (and probably not relevant) geometric differ-
ence between EgtB and CDO is the position of the thio-
late substrate bound to the metal with respect to super-
oxo. Interestingly, the carboxylic acid group of GC forms 
a salt bridge with Arg90, which is in almost the same posi-
tion as the Arg60 residue in CDO that forms the salt 
bridge with the cysteinate carboxylic acid group. The 
iron(III)-superoxo complexes of EgtB were optimized in 
three different snapshots, namely Sn945, Sn950 and Sn955 
and the singlet, triplet and quintet spin state structures 
are shown in Figure 2. In general, the optimized geome-
tries, particularly the iron-ligand distances, show little 
variation between the various snapshots and a maximum 
deviation well below 0.10Å is seen. Therefore, the starting 
structure taken from the MD simulation has little effect 
on the metal-ligand distances. The only major differences 
seen between the three snapshot structures for both spin 
states relates to the position of the two water molecules 
we included in the QM region. As a result some hydrogen 
bonding interactions involving the water molecules have 
changed considerably. However, this does not seem to 
affect the spin-state splitting and relative energies dra-
matically. 
Supporting Information Figure S3 gives an overlay of 
the crystal structure coordinates with that of Sn950 after 
full solvation and equilibration. In general, the MD snap-
shots have a similar fold as the crystal structure, although 
some groups have changed position slightly. One particu-
lar change relates to the aromatic ring of Tyr377 that is 
close to the iron center in the crystal structure, although 
in our iron(III)-superoxo optimized geometry it is slightly 
further away and the phenolate group of Tyr377 does not 
form a direct hydrogen bonding interaction with the su-
peroxo moiety but there is a bridging water molecule in 
between.   
The optimized geometries of the iron(III)-superoxo 
complexes of EgtB and CDO are very similar, particularly 
the metal-ligand distances. One noteworthy difference is 
the superoxo bond length, which is slightly longer in 
CDO at 1.32 – 1.35Å than in EgtB (1.29Å). Probably, this is 
due to the extensive hydrogen bonding network in EgtB 
that is lacking in CDO. As a result, the spin density distri-
bution is more polarized to the distal oxygen atom in 
CDO as compared to EgtB.  
The high-lying occupied and virtual orbitals are domi-
nated by the 3d orbital manifold on the metal and anti-
bonding interactions along the superoxo bond. The metal 
3d block splits into its usual t2g/eg sets of orbitals with 
three *-type orbitals (*xy, *xz and *yz) below the two of 
*-type orbitals (*x2-y2 and *z2).   
  
GC
TMH
Arg90
Tyr377
1.72 (1.73)
[[1.71 (1.81)]]
{2.51 (2.60)}
1.91 (1.91)
[[1.82 (2.57)]]
{1.99 (2.58)}
1.29 (1.29)
[[1.28 (1.23)]]
{1.29 (1.24)}
rFe‒O = 1.93 (2.03)
[[1.94 (2.06)]]
{1.93 (2.00)}
rFe‒S = 2.29 (2.40)
[[2.30 (2.49)]]
{2.30 (2.47)}
rFe‒N(TMH) = 2.00 (2.11)
[[2.02 (2.15)]]
{1.98 (2.11)}
3ReEgtB (
5ReEgtB) [
1ReEgtB]
rFe‒O = 1.90 (2.13) [1.90]
rFe‒S = 2.26 (2.50) [2.29]
rFe‒N(Cys) = 2.00 (2.14) [2.00]
3ReCDO (
5ReCDO) [
1ReCDO]
Arg60
Tyr157
Cys93
1.35 (1.32) [1.35]
Sn950 [[Sn945]] {Sn955}
[2.00]
[2.30]
[1.91]
[1.28] [1.73]
[1.96]
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Figure 3. Potential energy landscape for sulfoxide synthase starting from the iron(III)-superoxo complexes in the triplet and 
quintet spin states. Relative energies represent E+ZPE data in kcal mol
‒1
 as obtained at B3LYP/BS2//B3LYP/BS1:Charmm 
Electronically, the 1Re and 3Re structures refer to a state 
with configuration *xy
2 *xz
2 *yz
1 *OO
1. By contrast, the 
quintet spin state is formed after the promotion of a *xz 
electron into *z2. As expected from the orbital occupa-
tion, the singlet and triplet geometries are almost the 
same and at EBS1+ZPE level of theory we find both states 
close in energy. However, when the basis set is improved 
with polarization and diffuse functions, the singlet spin 
state is considerably destabilized. Despite the singlet spin 
state being the ground state in CDO, herein for EgtB a 
quintet spin state ground state is found. Again, most like-
ly this is due to the larger polarity of the iron(III)-
superoxo environment in EgtB as compared to CDO. One 
noteworthy difference found here between the 5Re mod-
els for EgtB and CDO is spin density located on the cys-
teinate substrate group: GC = 0.33 in EgtB and Cys = 0.05 
in CDO. The extra radical character on the substrate sul-
fur atom of the substrate in EgtB will make it more elec-
trophilic and enable an attack on the histidine substrate 
group.  
Relative energies show little variation between the 
three snapshots and, for instance, the triplet-quintet en-
ergy gap is calculated to be EBS1+ZPE = 4.3 [7.8] {5.3} kcal 
mol‒1 for snapshot Sn950 [Sn945] {Sn955}, respectively, in 
favor of the high-spin state at B3LYP/BS1:Charmm. Single 
point calculations with a larger basis set on atoms in the 
QM region gives a triplet-quintet energy gap of 4.2 kcal 
mol‒1 instead. This value matches the recent study of Liao 
et al18b who obtained 1.6 kcal mol–1 using a large DFT 
model of close to 200 atoms. Most studies reported in the 
literature on nonheme iron(IV)-oxo and iron(III)-
superoxo intermediates report a high-spin ground state in 
analogy to what is found here.36 It appears, therefore, that 
CDO is the anomaly in this series, which most probably 
originates from its highly apolar active site pocket and the 
lack of hydrogen bonding interactions to the oxo and su-
peroxo groups. 
 
Sulfoxide synthase mechanism of EgtB. Subsequent-
ly, we calculated the mechanism of sulfoxide synthase 
starting from the iron(III)-superoxo complexes and the 
obtained energy landscape (at the E+ZPE level of theory) 
is given in Figure 3. Although the reaction was proposed 
to start with a proton transfer from Tyr377 to iron(III)-
superoxo,14 instead the QM/MM mechanism reveals a 
proton-coupled electron-transfer. Thus, the distal oxygen 
atom of the iron(III)-superoxo group is protonated 
through a Grotthuss mechanism from Tyr377 via a bridging 
water molecule via a transition state (TSPT). However, at 
the same time an electron is transferred back from the 
tyrosinate to form the iron(III)-hydroperoxo complex (I1). 
Subsequently, a nucleophilic or radical attack of the sulfur 
atom on GC onto the CE1 atom of TMH via a transition 
state TSCS takes place that has the two substrates cova-
lently linked through a sulfide bond.   
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Figure 4. Optimized QM geometries of key intermediates in the catalytic cycle of EgtB as calculated with QM/MM as optimized 
at B3LYP/BS1:Charmm. Bond lengths are in angstroms and structures are taken for snapshot Sn950. The Arg90 residue is hidden to 
guide the eye. 
Simultaneously to the C‒S bond formation, i.e. along 
the pathway around TSCS (vide infra), the iron(III)-
hydroperoxo group relays its hydrogen atom back to 
Tyr377 and an electron is transferred from sulfur to iron to 
form an iron(II)-superoxo species (I2). In a the next reac-
tion step, the iron(II)-superoxo (I2) picks up a hydrogen 
atom from the sulfur-linked imidazole group via a transi-
tion state TSHA to form an iron(II)-hydroperoxo species 
and the sulfide bridged substrate, intermediate I3. In the 
final step of this mechanism the sulfoxidation takes place 
by the iron(II)-hydroperoxo intermediate to form the final 
R-sulfoxide product P. Our calculated mechanism leads 
to the product with the experimentally determined stere-
ochemistry,13b while a previous computational study led to 
the S-isomer instead.18b 
On all spin state surfaces starting from reactants, the 
hydrogen atom transfer from Tyr377 to the distal oxygen 
atom (Od) of the iron(III)-superoxo group requires a small 
barrier: 6.4 (17.1) kcal mol‒1 in the quintet (triplet) spin 
states with an almost thermoneutral driving force of ‒1.5 
(3.8) kcal mol‒1. The second reaction step in Figure 3 is 
rate determining and leads to formation of the carbon-
sulfur bond via TSCS, which splits the C=N double bond of 
the imidazole group of TMH back into a single bond and 
leaves a radical on the nitrogen atom. Our QM/MM cal-
culated mechanism up to 5I2 matches results recently re-
ported for a large DFT model complex very well,18b where 
a hydrogen atom abstraction barrier of 7.7 kcal mol–1 and 
a C–S bond formation step of 12.8 kcal mol–1 on the quin-
tet spin state was found. However, their mechanism after 
5TSCS converges to an iron(III)-hydroperoxo with high 
energy that was ruled out. In our QM/MM calculations 
the hydrogen bonding network, by contrast, enables a fast 
and simultaneous proton transfer to Tyr377 and gives a 
much lower lying iron(II)-superoxo intermediate. As a 
consequence, the C–S bond formation happens prior to 
the sulfoxidation in a low-energy alternative to the one 
proposed in Ref 18. Furthermore, the mechanism shown 
in Figure 3 supports experimental observation as will be 
discussed below.  
Note that during the C‒S bond formation the iron(III)-
hydroperoxo loses its proton back to Tyr377 simultaneous-
ly, as will be discussed in more detail later in this paper. 
In the triplet spin state this barrier is well over 40 kcal 
mol‒1 and hence no reactivity on the triplet spin state sur-
face can be expected. On the quintet spin state an S‒C 
bond formation barrier of 12.7 kcal mol‒1 is encountered. 
However, in the next step, the aromaticity is brought back 
into the imidazole ring through a hydrogen atom transfer 
to iron(II)-superoxo via another barrier of 4.4 kcal mol‒1 
above 5I2 to form an iron(II)-hydroperoxo complex I3 with 
a large exothermicity of well over 30 kcal mol‒1. Therefore, 
the step from 5I2 to 
5I3 will be irreversible. The final stage 
of the mechanism encounters negligible barrier heights 
and leads to the sulfoxide and an iron(III)-hydroxo com-
plex (P) in a strongly exothermic process. 
For the pathway from 5I2 to products, we also investi-
gated two alternatives, where the sulfoxidation happens 
prior to the hydrogen atom transfer, see Tables S16 and 
S17 in the Supporting Information. Thus, starting from 
structure 5I2 we scanned the S‒O distance between each 
of the oxygen atoms (distal and proximal) of the superoxo 
moiety to the sulfur atom of GC in a stepwise manner, 
whereby the S‒O distance was fixed at specific intervals 
and the rest of the structure was energy minimized. These 
two scans gave barrier heights of 8.4 and 5.9 kcal mol‒1 
with respect to the energy of 5I2, respectively, for transfer 
of the proximal or distal oxygen atom of iron(II)-superoxo 
to sulfur. The oxygen atom transfer values are higher in 
energy than the hydrogen atom abstraction barrier 5TSHA. 
Therefore, the QM/MM calculations predict an initial C‒S 
bond formation, followed by hydrogen transfer and con-
clude the reaction with the sulfoxidation mechanism.   
5TSPT (
3TSPT)
1.40 (1.41)
rFe‒O = 2.06 (1.88)
rFe‒S = 2.43 (2.28)
rFe‒N(TMH) = 2.12 (2.00)
1.32 (1.35)
5I1 (
3I1)
1.83 (2.03)
rFe‒O = 1.87 (1.82)
rFe‒S = 2.40 (2.35)
rFe‒N(TMH) = 2.17 (2.01)
1.40 (1.44)
5TSCS (
3TSCS)
1.70 (1.58)
rFe‒O = 2.09 (1.86)
rFe‒S = 3.14 (3.13)
rFe‒N(TMH) = 2.12 (1.99)
rS‒C = 1.98 (1.93)
1.31 (1.34)
5TSHA
1.60
rFe‒O = 1.94
rFe‒S = 3.86
rFe‒N(TMH) = 2.15
rS‒C = 1.87
1.43
rO‒H = 1.48
rH‒C = 1.24
rOO‒H = 1.15 (1.21)
rH‒OH = 1.27 (1.23)
Page 7 of 14
ACS Paragon Plus Environment
Journal of the American Chemical Society
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
8 
 
 
Figure 5. Geometry scan for the C–S bond formation step from 
5
I1 (right-hand-side) to 
5
I2 (left-hand-side). Energies taken rela-
tive to 
5
I1 as obtained with QM/MM at B3LYP/BS1:Charmm using fixed C–S bond distance. Also shown are extracts of geometries 
with bond lengths in angstroms. 
It should be mentioned here that the scans for the dis-
tal or proximal oxygen atom transfer from 5I2 reached a 
maximum in energy, and consequently a reaction barrier 
for sulfoxidation from intermediate 5I2. However, beyond 
these barriers the C–S bond broke again and a local min-
imum was reached where a bridging Fe‒O‒O‒S interme-
diate was formed, similar to the initial oxygen activation 
step in CDO enzymes.17 As such, these oxygen atom trans-
fer pathways from intermediate 5I2 may not be viable. 
Optimized QM/MM geometries of key intermediates 
along the reaction mechanism of Figure 3 are shown in 
Figure 4. In general, the optimized geometries are not 
dramatically different from those obtained for analogous 
nonheme iron dioxygenases calculated previously.37,38 In 
3,5TSPT the tyrosinate is already deprotonated and has lost 
its proton to a bridging water molecule. In the transition 
state this bridging water molecule, which formally is 
H3O
+, transfers one of its protons to the distal oxygen 
atom of the iron(II)-superoxo group. In 5TSPT (
3TSPT) the 
transferring proton is located almost midway in between 
these groups, namely at a distance of 1.15 (1.21)Å to the 
distal oxygen atom and at 1.27 (1.23)Å from the oxygen 
atom of the water molecule, respectively.  
At this stage the metal-ligand distances retain their val-
ues from the reactant complexes and only a small elonga-
tion in the Fe‒O distance is seen. In these transition 
states spin density is starting to accumulate on the Tyr377 
group (Tyr = 0.46 in 
3TSPT and Tyr = 0.47 in 
5TSPT), which 
implicates that a proton-coupled-electron-transfer takes 
place, whereby simultaneously to the protonation of the 
superoxo group the metal abstracts an electron from tyro-
sinate. 
In the first intermediate (I1), the Tyr377 group contains a 
radical (Tyr = 1.00 in 
3,5I1) and is connected to a hydrogen 
bonding chain of water molecules to iron(III)-
hydroperoxo. The distal hydroxo group is in hydrogen 
bonding distance (2.86Å in 5I1) to the thiolate group of 
GC. In general, protonation of the superoxo group leads 
to elongation of the O‒O bond from about 1.29Å in 3,5Re 
to 1.40/1.44Å in 5I1/
3I1. The electronic configuration of 
these intermediates identifies 5,3I1 as iron(III)-hydroperoxo 
complexes with orbital occupation *xy
2 *xz
2 *yz
1 Tyr
1 in 
0
5
10
15
20
1.5 2.0 2.5 3.0 3.5 4.0
E
[kcal mol1]
CS distance [angstroms]
2.87
1.62
1.77
2.33
2.34
1.79
1.65
2.72 1.00
2.24
1.80
1.66
2.77 1.00
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the triplet spin state and *xy
2 *xz
1 *yz
1 *z2
1 Tyr
1 in the 
quintet spin state, whereby Tyr represents the singly oc-
cupied orbital on the Tyr377 group.. Attempts were made 
to swap molecular orbitals to obtain an intermediate 3I1’ 
with *xy
2 *xz
 *yz
 *z2
 Tyr
 configuration but the wave 
function converged back to the 3I1 state reported above. 
Several pathways were investigated for the next step in 
the catalytic cycle, but we will focus on the lowest energy 
mechanism first. In the next section the alternative 
mechanisms will be described. The thiolate group of GC 
attacks the CE1 atom of TMH through a nucleo-
philic/radical attack in 3,5TSCS. In the transition state the 
C‒S distance is shortened to 1.98 (1.93)Å in the quintet 
(triplet) spin state, respectively. At this stage, the Fe‒S 
bond breaks and distances of well over 3Å are recorded 
and consequently, the metal is reduced from six-
coordination to five-coordination. In the transition state 
this results in the conversion of iron(II)-hydroperoxo into 
iron(II)-superoxo through a proton-coupled-electron-
transfer to Tyr377 that changes from a tyrosinyl radical to a 
tyrosine residue. This step has a very high barrier in the 
triplet spin state and consequently, we did not investigate 
the rest of the mechanism on this spin state. 
The C‒S bond formation results in the breaking of the 
aromaticity in the imidazole group of TMH and creates a 
radical on the substrate. The iron(II)-superoxo group at-
tacks the radical by abstracting the proton from the CE1 
position, so that the imidazole group reverts back to an 
aromatic ring and hence gains stabilization energy. In 
5TSHA the transferring proton is at a distance of 1.48Å 
from the distal oxygen atom and at 1.24Å from the carbon 
atom of TMH. 
Details of the C–S bond formation pathway are given in 
the geometry scan displayed in Figure 5. Thus, upon ap-
proach of the thiolate of GC on the TMH substrate the 
iron(II)-hydroperoxo group remains protonated. Howev-
er, when a short interaction between sulfur and carbon is 
reached, e.g. below 2.34Å, the proton moves rapidly to the 
tyrosine group and to form iron(II)-superoxo. This hap-
pens almost simultaneously with the C‒S bond formation 
that links the two substrates. Group spin densities give 
radical character on the tyrosinate group until a C‒S dis-
tance of 2.87Å is reached. At shorter distances, however, a 
proton coupled electron transfer happens and the radical 
character on Tyr377 disappears and at the same time in-
creases on the TMH and GC groups. Therefore, at short 
range the attacking nucleophile gains radical character. 
The electron- and proton-transfer to Tyr377 that occur en 
route from I1 to 
5TSCS indicate that I1 must be in 
equilibrium with a less stable intermediate that contains a 
thiyl radical, an iron(II)-superoxo species and Tyr377 in 
reduced and protonated form. Unfortunately, an orbital 
swap from 5I1 to attempt to generate this thiyl radical 
configuration failed and converged back to 5I1 instead. In 
contrast to I1 this species (I1b) could approach the 
transition state without requiring en route proton- and 
outer sphere electron transfer (Scheme 3).  
 
 
Scheme 3. Isoelectronic forms of I1. 
 
After the hydrogen atom abstraction the system relaxes 
to intermediate 5I3, which is an iron(II)-hydroperoxo with 
the metal in five-coordination. Both distal (Od) and prox-
imal (Op) oxygen atoms of the hydroperoxo group in 
5I3 
are at almost equal distance to the sulfur atom: the S‒Od 
distance is 3.24Å and the S‒Op one is 3.18Å. We find an 
almost barrierless pathway from 5I3 to 
5P leading to an 
iron(II)-hydroxo and sulfoxide product complex (5P) with 
a large exothermicity, whereby the attack on sulfur hap-
pens through the OH terminal group of the iron(II)-
hydroperoxo complex. We also attempted to transfer the 
proximal oxygen atom to sulfur instead but encountered a 
high energy pathway (Supporting Information) and, 
therefore, this is not a feasible mechanism. 
Figure 6. Optimized QM geometry of the S–O bond for-
mation transition state for the reaction of iron(III)-superoxo 
with cysteine in EgtB. Data obtained with QM/MM at the 
B3LYP/BS1:Charmm level of theory with bond lengths in ang-
stroms. 
 
 
Cysteine dioxygenase pathway. In CDO enzymes an 
iron(III)-superoxo species is formed that reacts by con-
TMH
GC
rO-O: 1.38
rFe-O: 1.95
rO-S: 2.18
rFe-S: 2.56
5TSSO
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secutive oxygen atom transfer to the sulfur atom of cyste-
ine substrate to form cysteine sulfinic acid.3,17,39 We tested 
this mechanism for EgtB as well starting from 5,3Re by 
initially scanning the S–Od distance through stepwise 
geometry optimizations with fixed S–O distance. Subse-
quently, the S–O bond formation transition state (TSSO) 
was optimized and the quintet structure is given in Figure 
6. We also located a triplet spin barrier but found it well 
higher in energy by at least 30 kcal mol–1, therefore, will 
not consider it further. 
The 5TSSO structure shown in Figure 6 shows strong 
similarities to the analogous structure reported for CDO 
enzymes and calculated with QM/MM, where Fe–O, O–
O, O–S and Fe–S distances of 1.93, 1.31, 2.23 and 2.84 Å 
were obtained, respectively.17b The only difference comes 
from a much shorter Fe–S distance of 2.56 Å, which prob-
ably relates to the choice of the basis set, which previous-
ly was shown to strongly affect calculated Fe–S distanc-
es.40   
Energetically, in CDO the 5TSSO barrier was located at 
EQM/MM + ZPE = 14.4 kcal mol
–1.17b By contrast, a value of 
13.1 kcal mol–1 for our EgtB model calculated here is found. 
As such, little changes in barrier height of sulfur activa-
tion by iron(III)-superoxo is found upon changing the 
substrate and the protein environment. Nevertheless, the 
CDO-type mechanism is higher in energy than the hydro-
gen abstraction from Tyr377 and hence, the latter will be 
the favorable pathway for EgtB. Consequently, the Tyr377 
amino acid has an essential function in EgtB to prevent 
direct dioxygenation of the sulfur-containing substrate 
and guide the reaction mechanism to the preferred C‒S 
bond formation step. Indeed, studies on the Y377F mu-
tant of EgtB gave dominant sulfur dioxygenation through 
a CDO-type reaction mechanism.14 The experimental ob-
servation that the Y377F mutant still has 0.1 % of the wild 
type sulfoxide synthase activity may imply a second pro-
ton source in the catalytic cycle. An analysis of our opti-
mized structures (Figure S4) proposes a possible role for 
Tyr380.  
Figure 7. Alternative reaction pathways for the sulfoxide synthase mechanism of EgtB. Explanations see text. Barriers are given 
in kcal mol
–1
 relative to 
5
Re. 
Alternative mechanisms and by-product channels. 
Although the low-energy process described in Figures 3 
and 4 appears to give accessible energies for the protein at 
room temperature, we investigated also a series of alter-
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native pathways to rule out the formation of side reac-
tions and by-products, Figure 7. As some nonheme 
iron(III)-superoxo complexes of dioxygenases and syn-
thetic model complexes are known to react through hy-
drogen atom abstraction with substrates,41 we decided to 
investigate the hydrogen atom abstraction of the CE1‒H 
bond by the reactant complexes 3,5Re in snapshot Sn950 
(middle reaction from Re in Figure 7). We find a high 
energy pathway that does not plateau into a local mini-
mum, however. Therefore, a hydrogen atom abstraction 
by iron(III)-superoxo from the imidazole ring is difficult 
and possibly only achievable when the hybridization of 
CE1 changes from sp2 to sp3, e.g., through covalent bind-
ing of the sulfide. Hence, a reaction mechanism starting 
with hydrogen atom abstraction from CE1 will not be a 
likely pathway and has to follow the C‒S bond formation 
step. Therefore, we also calculated the C–S bond for-
mation step starting from the iron(III)-superoxo complex 
(5Re), but here as well a high energy pathway was found. 
Therefore, from the iron(III)-superoxo reactant complex a 
proton transfer from TMH and a C–S bond formation step 
can both be ruled out. Consequently, the iron(III)-
superoxo will only react through either oxygen atom 
transfer (OAT) to thiolate or pick up a proton from a pro-
ton source such as Tyr377. 
Of all pathways starting from the reactant complexes, 
the lowest energy reaction channel is the proton-coupled-
electron-transfer from Tyr377 to the iron(III)-superoxo 
group to form iron(III)-hydroperoxo for which we located 
a barrier of only 6.4 kcal mol‒1 (see Figure 3 above). Most 
probably, the energy of the reverse reaction is just high 
enough to prevent full equilibration between the reactant 
and I1 structures and the reaction will continue from I1. 
The obtained iron(III)-hydroperoxo species, however, is 
unable to react with the thiolate group of GC via a dioxy-
genation reaction as the calculated pathway gives a high 
energy process. Therefore, the protonation of the super-
oxo group is an essential initial step in the reaction mech-
anism to prevent the thiol dioxygenation reaction. 
Subsequently, we considered a variety of possible reac-
tion pathways starting from structure I1. As shown above 
in Figure 3 a C–S bond formation step of 12.7 kcal mol–1 
above reactants leads to intermediate I2. The alternative 
mechanisms tested included a hydrogen atom abstraction 
from TMH by either the iron(II)-hydroperoxo group or 
directly to Tyr377. The direct proton transfer from the CE1‒
H group of TMH via a chain of water molecules to Tyr377 
was attempted through a geometry scan by relaying the 
hydrogen atom to a bridging water molecule. However, 
this scan did not lead to a maximum in energy and no 
stable product structure was found, but instead the ener-
gy continuously increased. Consequently, direct hydrogen 
atom transfer from TMH to Tyr377 is difficult and the 
bridging water molecules are unable to relay hydrogen 
atoms directly and no direct connection between Tyr and 
TMH exists. Clearly, water molecules are able to relay 
protons through a Grotthuss-type mechanism but not 
hydrogen atoms.  
In addition, we investigated a hydrogen atom abstrac-
tion from the CE1‒H group of TMH by the iron(II)-
hydroperoxo moiety to form iron(IV)-oxo and a water 
molecule. Although the iron(III)-hydroperoxo group is 
located in proximity of the CE1–H group, it appears ener-
getically unfeasible to abstract a hydrogen atom. In par-
ticular, the geometry scans had high maxima with values 
of about 32 and 47 kcal mol‒1 on the quintet and triplet 
spin state with respect to either 5I1 or 
3I1. Consequently, 
the iron(III)-hydroperoxo species cannot act as an oxidant 
in the reaction mechanism and should react via hydrogen 
atom abstraction from substrate. Thus, the mechanism 
presented in Figure 3 is the lowest energy pathway for 
sulfoxide synthase by EgtB. Alternative reaction steps 
were tested and all were ruled out. Furthermore, many 
different plausible mechanisms have been reported and 
proposed in the literature.13,14,18,19,42 However, none of the 
mechanisms agrees on the sequence of the individual 
bond making and breaking events in the reaction cycle of 
EgtB. The major disagreement lies in the question as to 
whether sulfoxidation of GC preceeds C‒S bond for-
mation18,42a or vice versa.14 Our QM/MM studies support 
the latter in a novel mechanism that prevents dioxygena-
tion of the cysteinate substrate. A key result we have ob-
tained relates to a low-energy pathway that relies on 
Tyr377 as a transient electron- and proton-donor to the 
iron(III)-superoxide species. This proposal provides an 
intuitive mechanism by which Tyr377 can prevent GC di-
oxygenation, but also implicates that Tyr377 is not directly 
involved with C‒H bond cleavage. The latter agrees well 
with the experimental observation that mutation of Tyr377 
to phenylalanine does not make C‒H bond cleavage rate 
limiting.43  
Recent calculations by Siegbahn et al.18b examined the 
sulfoxidation-first route and produced a plausible mecha-
nism. However, they predict a steady-state solvent kinetic 
isotope effect (KIE) that was not observed experimental-
ly.43 Moreover, the sulfoxide product stereochemistry 
does not fit the empirical structure of the derived prod-
uct.13b Furthermore, their model suggests that the path-
ways towards sulfoxide and dioxide products bifurcate 
after irreversible sulfoxidation of GC. According to the 
corresponding energy landscape all intermediates after 
sulfoxidation and before C‒H bond cleavage are in equi-
librium. Therefore, one would expect that deuterated 
TMH should reduce the sulfoxide to GC dioxide ratio. At 
least for the Tyr377Phe mutant of EgtB this substrate KIE 
on product distribution was not observed.43 
 
Conclusions. 
In conclusion, we have performed a high-level QM/MM 
study on the mechanism of sulfoxide synthase by EgtB 
enzymes, which is an enzyme involved in the biosynthesis 
of ergothioneine, an important natural amino acid in-
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volved in aging and anti-oxidant behavior in cells.44 These 
enzymes utilize molecular oxygen on a nonheme iron 
center that show structural and functional analogy to cys-
teine dioxygenase, but the reaction catalyzed by EgtB is 
remarkably complicated. In particular, it requires C‒H 
and O‒O bond cleavage and simultaneous C‒S and S‒O 
bond formation. We show, for the first time, that an ac-
tive site tyrosine residue triggers protonation of the 
iron(III)-superoxo structure via a proton-coupled-
electron-transfer. This is a low-energy pathway that pre-
vents the iron(III)-superoxo group to react with sulfide 
and form cysteine sulfinic acid side-products. Instead, a 
subsequent C–S bond formation step is triggered by sul-
foxidation followed by proton transfer from iron(III)-
hydroperoxo to tyrosine. Alternative mechanisms were 
tested and ruled out as viable reaction pathways. 
The calculations presented in this work show the sul-
foxide synthase reaction is a challenging process in chem-
istry as many competing mechanisms may occur. Thus, 
Nature has created a specific enzyme class for this reac-
tion, whereby a low-energy cysteine dioxygenation reac-
tion is prevented through a proton-coupled-electron-
transfer to form an iron(III)-hydroperoxo species. That 
way, a pathway is generated for C‒S bond formation be-
tween the cysteinate and imidazole groups of the two 
substrates. As such, the sulfoxide synthase reaction re-
quires the bond formation processes in a specific order to 
obtain the required products. This is an important lesson 
for the future development for catalysts involved in reac-
tion mechanisms for sulfoxide synthase type pathways 
and could make it a valuable template for the design of 
tailor-made biocatalysts. 
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